EFFECTS OF LONG-TERM ORAL-ADMINISTRATION OF AMIODARONE ON THE ELECTROMECHANICAL PERFORMANCE OF RABBIT VENTRICULAR MUSCLE

被引:36
作者
KODAMA, I
SUZUKI, R
KAMIYA, K
IWATA, H
TOYAMA, J
机构
[1] Department of Circulation, Research Institute of Environmental Medicine, Nagoya University, Nagoya
关键词
AMIODARONE; VENTRICULAR MUSCLE; ACTION POTENTIAL; VMAX; FREQUENCY-DEPENDENCE;
D O I
10.1111/j.1476-5381.1992.tb12774.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of long-term administration of oral amiodarone on transmembrane action potential and contraction of ventricular muscle were investigated in rabbits. 2 ECGs of rabbits that received oral amiodarone 50 mg or 100 mg kg-1 daily for 4 weeks, showed a significant prolongation of RR, QT and corrected QT (QTc) intervals, whereas PQ and QRS were unaffected. Serum and myocardial tissue amiodarone concentrations were 0.14-0.18 mug ml-1 and 1.47-3.63 mug g-1 wet wt. respectively. 3 Right ventricular papillary muscles isolated from treated rabbits were characterized by a moderate prolongation of action potential duration (APD) compared with controls. A slight decrease of the maximum upstroke velocity (V(max)) was also observed at the higher dose. The APD prolongation by chronic amiodarone, unlike acute effects of sotalol, E-4031, Cs+ and 4-aminopyridine, did not show marked reverse use-dependence. 4 APD and V(max) restitution following slow basic stimuli (0.03 Hz) were unaffected by chronic treatment with amiodarone. 5 Acute application of amiodarone (10 muM) caused a significant decrease in APD and developed tension, as well as a marked use-dependent V(max) inhibition with fast recovery kinetics. 6 These findings suggest that a major and consistent electro-physiological effect of chronic amiodarone is repolarization delay (Class-III action) showing minimal frequency-dependence. However, when amiodarone above a certain concentration is present in the extracellular space, a fast kinetic Class-I action would be added as an acute effect.
引用
收藏
页码:502 / 509
页数:8
相关论文
共 37 条
[31]  
SINGH BN, 1990, ANTIARRHYTHMIC DRUGS, P335
[32]   USE-DEPENDENT EFFECTS OF AMIODARONE ON VMAX IN CARDIAC PURKINJE AND VENTRICULAR MUSCLE-FIBERS [J].
VARRO, A ;
NAKAYA, Y ;
ELHARRAR, V ;
SURAWICZ, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 112 (03) :419-422
[33]   ELECTROPHARMACOLOGY OF AMIODARONE - ABSENCE OF RELATIONSHIP TO SERUM, MYOCARDIAL, AND CARDIAC SARCOLEMMAL MEMBRANE DRUG CONCENTRATIONS [J].
VENKATESH, N ;
SOMANI, P ;
BERSOHN, M ;
PHAIR, R ;
KATO, R ;
SINGH, BN .
AMERICAN HEART JOURNAL, 1986, 112 (05) :916-922
[34]   A CLASSIFICATION OF ANTIARRHYTHMIC ACTIONS REASSESSED AFTER A DECADE OF NEW DRUGS [J].
WILLIAMS, EMV .
JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (04) :129-147
[35]   ACUTE EFFECTS OF AMIODARONE ON THE ELECTROPHYSIOLOGIC PROPERTIES OF ISOLATED NEONATAL AND ADULT CARDIAC FIBERS [J].
YABEK, SM ;
KATO, R ;
SINGH, BN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (05) :1109-1115
[36]   EFFECTS OF AMIODARONE AND ITS METABOLITE, DESETHYLAMIODARONE, ON THE ELECTROPHYSIOLOGIC PROPERTIES OF ISOLATED CARDIAC-MUSCLE [J].
YABEK, SM ;
KATO, R ;
SINGH, BN .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (01) :197-207
[37]   AMIODARONE - ELECTROPHYSIOLOGIC ACTIONS, PHARMACOKINETICS AND CLINICAL EFFECTS [J].
ZIPES, DP ;
PRYSTOWSKY, EN ;
HEGER, JJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (04) :1059-1071